title: Irreversible Electroporation as an Effective Technique for Ablating Human Metastatic Osteosarcoma.
abstract: Irreversible electroporation (IRE) induces apoptosis in tumor cells with electric energy, allowing treatment of unresectable tumors. One potential application is metastatic osteosarcoma (OS) in the pediatric population. A 12-year-old underwent thoracotomy with resection of metastatic OS. IRE was applied to 1 resected tumor section. Using 2 probes, 100 pulses with width of 90 ms were delivered. Efficacy was measured by increase in current draw during treatment. The treated sample was analyzed with hematoxylin and eosin and transmission electron microscopy. Default voltage of 1800 kV was ineffective. Voltage of 2700 kV caused excessive current draw and was aborted to prevent thermal injury. At 2200 kV, current draw rise was 9 amps, signifying successful treatment. Untreated specimen showed viable OS, normal surrounding lung tissue. Treated tumor had edema within the tumor and in surrounding lung tissue, with intra-alveolar hemorrhage and cellular architecture destruction. There was also evidence for cellular destruction such as disruption of lipid bilayer and release of intracellular fluid. Optimal voltage for treatment was 2200 kV, likely higher due to electrical conduction variation in the aerated lung. IRE may be an option for pediatric patients with unresectable metastatic OS.
authors.affiliation: Departments of *Surgery †Interventional Radiology §Pathology, Rush University Medical Center ‡Department of Pathology, University of Illinois at Chicago, Chicago, IL.
authors.forename: Jamie C
authors.initials: JC
authors.lastname: Harris
authors.forename: Allen
authors.initials: A
authors.lastname: Chen
authors.forename: Virgilia
authors.initials: V
authors.lastname: Macias
authors.forename: Brett
authors.initials: B
authors.lastname: Mahon
authors.forename: Bill
authors.initials: B
authors.lastname: Chiu
authors.forename: Srikumar
authors.initials: S
authors.lastname: Pillai
mesh_terms: D001859:Bone Neoplasms / Q000473:pathology / Q000628:therapy*; D002648:Child; D053672:Electrochemotherapy / Q000379:methods*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary* / Q000628:therapy*; D012516:Osteosarcoma / Q000556:secondary / Q000628:therapy*